{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:39:19Z","timestamp":1793320759176,"version":"4.5.0"},"reference-count":196,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T00:00:00Z","timestamp":1581379200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T00:00:00Z","timestamp":1581379200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Parkinson\u2019s disease (PD) is a neurodegenerative disorder that results in the death of dopaminergic neurons within the<jats:italic>substantia nigra pars compacta<\/jats:italic>and the reduction in dopaminergic control over striatal output neurons, leading to a movement disorder most commonly characterized by akinesia or bradykinesia, rigidity and tremor. Also, PD is less frequently depicted by sensory symptoms (pain and tingling), hyposmia, sleep alterations, depression and anxiety, and abnormal executive and working memory related functions. On the other hand, insulin-like growth factor 1 (IGF-1) is an endocrine, paracrine and autocrine hormone with several functions including tissue growth and development, insulin-like activity, proliferation, pro-survival, anti-aging, antioxidant and neuroprotection, among others. Herein this review tries to summarize all experimental and clinical data to understand the pathophysiology and development of PD, as well as its clear association with IGF-1, supported by several lines of evidence: (1) IGF-1 decreases with age, while aging is the major risk for PD establishment and development; (2) numerous basic and translational data have appointed direct protective and homeostasis IGF-1 roles in all brain cells; (3) estrogens seem to confer women strong protection to PD via IGF-1; and (4) clinical correlations in PD cohorts have confirmed elevated IGF-1 levels at the onset of the disease, suggesting an ongoing compensatory or \u201cfight-to-injury\u201d mechanism.<\/jats:p>","DOI":"10.1186\/s12967-020-02223-0","type":"journal-article","created":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T17:05:41Z","timestamp":1581440741000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Is insulin-like growth factor-1 involved in Parkinson\u2019s disease development?"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2230-5927","authenticated-orcid":false,"given":"Inma","family":"Castilla-Cort\u00e1zar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel A.","family":"Aguirre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovana","family":"Femat-Rold\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Mart\u00edn-Estal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,11]]},"reference":[{"issue":"1","key":"2223_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/mds.870010104","volume":"1","author":"CG Goetz","year":"1986","unstructured":"Goetz CG. Charcot on Parkinson\u2019s disease. Mov Disord. 1986;1(1):27\u201332.","journal-title":"Mov Disord"},{"issue":"4","key":"2223_CR2","doi-asserted-by":"publisher","first-page":"a033118","DOI":"10.1101\/cshperspect.a033118","volume":"10","author":"MG Erkkinen","year":"2018","unstructured":"Erkkinen MG, Kim M-O, Geschwind MD. Clinical neurology and epidemiology of the major neurodegenerative diseases. Cold Spring Harb Perspect Biol. 2018;10(4):a033118.","journal-title":"Cold Spring Harb Perspect Biol."},{"issue":"11","key":"2223_CR3","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","volume":"17","author":"GBD 2016 Parkinson\u2019s Disease Collaborators","year":"2018","unstructured":"GBD 2016 Parkinson\u2019s Disease Collaborators. Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17(11):939\u201353.","journal-title":"Lancet Neurol."},{"issue":"4","key":"2223_CR4","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","volume":"79","author":"J Jankovic","year":"2008","unstructured":"Jankovic J. Parkinson\u2019s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008;79(4):368\u201376.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"2223_CR5","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/S1474-4422(09)70293-5","volume":"8","author":"MC Rodriguez-Oroz","year":"2009","unstructured":"Rodriguez-Oroz MC, Jahanshahi M, Krack P, Litvan I, Macias R, Bezard E, et al. Initial clinical manifestations of Parkinson\u2019s disease: features and pathophysiological mechanisms. Lancet Neurol. 2009;8(12):1128\u201339.","journal-title":"Lancet Neurol"},{"issue":"5","key":"2223_CR6","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1002\/mds.25019","volume":"27","author":"CW Olanow","year":"2012","unstructured":"Olanow CW, Obeso JA. The significance of defining preclinical or prodromal Parkinson\u2019s disease. Mov Disord. 2012;27(5):666\u20139. https:\/\/doi.org\/10.1002\/mds.25019.","journal-title":"Mov Disord"},{"issue":"23","key":"2223_CR7","doi-asserted-by":"publisher","first-page":"5981","DOI":"10.1111\/febs.12335","volume":"280","author":"PMA Antony","year":"2013","unstructured":"Antony PMA, Diederich NJ, Kr\u00fcger R, Balling R. The hallmarks of Parkinson\u2019s disease. FEBS J. 2013;280(23):5981\u201393. https:\/\/doi.org\/10.1111\/febs.12335.","journal-title":"FEBS J"},{"issue":"9996","key":"2223_CR8","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE. Parkinson\u2019s disease. Lancet. 2015;386(9996):896\u2013912.","journal-title":"Lancet"},{"issue":"5","key":"2223_CR9","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S1474-4422(13)70047-4","volume":"12","author":"D Berg","year":"2013","unstructured":"Berg D, Lang AE, Postuma RB, Maetzler W, Deuschl G, Gasser T, et al. Changing the research criteria for the diagnosis of Parkinson\u2019s disease: obstacles and opportunities. Lancet Neurol. 2013;12(5):514\u201324.","journal-title":"Lancet Neurol"},{"issue":"2","key":"2223_CR10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/jnp.12028","volume":"7","author":"G Dirnberger","year":"2013","unstructured":"Dirnberger G, Jahanshahi M. Executive dysfunction in Parkinson\u2019s disease: a review. J Neuropsychol. 2013;7(2):193\u2013224. https:\/\/doi.org\/10.1111\/jnp.12028.","journal-title":"J Neuropsychol"},{"issue":"1","key":"2223_CR11","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/mds.22874","volume":"25","author":"C Juri","year":"2010","unstructured":"Juri C, Rodr\u00edguez-Oroz MC, Burguera JA, Guridi J, Obeso JA. Pain and dyskinesia in Parkinson\u2019s disease. Mov Disord. 2010;25(1):130\u20132.","journal-title":"Mov Disord"},{"issue":"Pt 2","key":"2223_CR12","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1093\/brain\/123.2.394","volume":"123","author":"U Sabatini","year":"2000","unstructured":"Sabatini U, Boulanouar K, Fabre N, Martin F, Carel C, Colonnese C, et al. Cortical motor reorganization in akinetic patients with Parkinson\u2019s disease: a functional MRI study. Brain. 2000;123(Pt 2):394\u2013403.","journal-title":"Brain"},{"issue":"SUPPL. 17","key":"2223_CR13","doi-asserted-by":"publisher","first-page":"S335","DOI":"10.1002\/mds.21675","volume":"22","author":"CW Olanow","year":"2007","unstructured":"Olanow CW. The pathogenesis of cell death in Parkinson\u2019s disease\u20142007. Mov Disord. 2007;22(SUPPL. 17):S335\u201342.","journal-title":"Mov Disord."},{"issue":"1","key":"2223_CR14","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","volume":"318","author":"H Braak","year":"2004","unstructured":"Braak H, Ghebremedhin E, R\u00fcb U, Bratzke H, Del Tredici K. Stages in the development of Parkinson\u2019s disease-related pathology. Cell Tissue Res. 2004;318(1):121\u201334.","journal-title":"Cell Tissue Res"},{"issue":"3","key":"2223_CR15","first-page":"R203","volume":"241","author":"JW Mink","year":"1981","unstructured":"Mink JW, Blumenschine RJ, Adams DB. Ratio of central nervous system to body metabolism in vertebrates: its constancy and functional basis. Am J Physiol. 1981;241(3):R203\u201312.","journal-title":"Am J Physiol"},{"issue":"Suppl","key":"2223_CR16","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1002\/ana.410320710","volume":"32","author":"JR Connor","year":"1992","unstructured":"Connor JR, Benkovic SA. Iron regulation in the brain: histochemical, biochemical, and molecular considerations. Ann Neurol. 1992;32(Suppl):S51\u201361.","journal-title":"Ann Neurol"},{"issue":"1","key":"2223_CR17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4155\/fmc.09.140","volume":"2","author":"E Mills","year":"2010","unstructured":"Mills E, Dong X-P, Wang F, Xu H. Mechanisms of brain iron transport: insight into neurodegeneration and CNS disorders. Future Med Chem. 2010;2(1):51\u201364.","journal-title":"Future Med Chem."},{"issue":"13","key":"2223_CR18","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1212\/WNL.0b013e3182a55ea5","volume":"81","author":"NK Patel","year":"2013","unstructured":"Patel NK, Pavese N, Javed S, Hotton GR, Brooks DJ, Gill SS. Benefits of putaminal GDNF infusion in Parkinson disease are maintained after GDNF cessation. Neurology. 2013;81(13):1176\u20138.","journal-title":"Neurology."},{"issue":"3","key":"2223_CR19","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/00001756-199902250-00021","volume":"10","author":"K Parain","year":"1999","unstructured":"Parain K, Murer MG, Yan Q, Faucheux B, Agid Y, Hirsch E, et al. Reduced expression of brain-derived neurotrophic factor protein in Parkinson\u2019s disease substantia nigra. Neuroreport. 1999;10(3):557\u201361.","journal-title":"Neuroreport"},{"issue":"13","key":"2223_CR20","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/mds.25945","volume":"29","author":"T Pringsheim","year":"2014","unstructured":"Pringsheim T, Jette N, Frolkis A, Steeves TDL. The prevalence of Parkinson\u2019s disease: a systematic review and meta-analysis. Mov Disord. 2014;29(13):1583\u201390.","journal-title":"Mov Disord"},{"issue":"4","key":"2223_CR21","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1159\/000445751","volume":"46","author":"L Hirsch","year":"2016","unstructured":"Hirsch L, Jette N, Frolkis A, Steeves T, Pringsheim T. The incidence of Parkinson\u2019s disease: a systematic review and meta-analysis. Neuroepidemiology. 2016;46(4):292\u2013300.","journal-title":"Neuroepidemiology."},{"issue":"11","key":"2223_CR22","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/aje\/kwg068","volume":"157","author":"SK Van Den Eeden","year":"2003","unstructured":"Van Den Eeden SK. Incidence of Parkinson\u2019s disease: variation by age, gender, and race\/ethnicity. Am J Epidemiol. 2003;157(11):1015\u201322.","journal-title":"Am J Epidemiol."},{"key":"2223_CR23","first-page":"64","volume":"16","author":"M Rodr\u00edguez-Violante","year":"2011","unstructured":"Rodr\u00edguez-Violante M, Villar-Velarde A, Valencia-Ramos C, Cervantes-Arriaga A. Caracter\u00edsticas epidemiol\u00f3gicas de pacientes con enfermedad de Parkinson Arch Neurocien (Mex) INNN. Arch Neurocien. 2011;16:64\u20138.","journal-title":"Arch Neurocien"},{"issue":"15","key":"2223_CR24","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1212\/WNL.0000000000002461","volume":"86","author":"G Pagano","year":"2016","unstructured":"Pagano G, Ferrara N, Brooks DJ, Pavese N. Age at onset and Parkinson disease phenotype. Neurology. 2016;86(15):1400\u20137.","journal-title":"Neurology."},{"issue":"12","key":"2223_CR25","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1007\/s10072-014-1879-1","volume":"35","author":"Y Song","year":"2014","unstructured":"Song Y, Gu Z, An J, Chan P. Gender differences on motor and non-motor symptoms of de novo patients with early Parkinson\u2019s disease. Neurol Sci. 2014;35(12):1991\u20136.","journal-title":"Neurol Sci."},{"issue":"4","key":"2223_CR26","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1159\/000201565","volume":"32","author":"M Yamawaki","year":"2009","unstructured":"Yamawaki M, Kusumi M, Kowa H, Nakashima K. Changes in prevalence and incidence of Parkinson\u2019s disease in Japan during a quarter of a century. Neuroepidemiology. 2009;32(4):263\u20139.","journal-title":"Neuroepidemiology."},{"issue":"3","key":"2223_CR27","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.yfrne.2014.02.002","volume":"35","author":"GE Gillies","year":"2014","unstructured":"Gillies GE, Pienaar IS, Vohra S, Qamhawi Z. Sex differences in Parkinson\u2019s disease. Front Neuroendocrinol. 2014;35(3):370\u201384.","journal-title":"Front Neuroendocrinol"},{"issue":"8","key":"2223_CR28","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1136\/jnnp.2008.168211","volume":"80","author":"G Alves","year":"2009","unstructured":"Alves G, M\u00fcller B, Herlofson K, HogenEsch I, Telstad W, Aarsland D, et al. Incidence of Parkinson\u2019s disease in Norway: the Norwegian ParkWest study. J Neurol Neurosurg Psychiatry. 2009;80(8):851\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"2223_CR29","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1210\/endo.138.3.4979","volume":"138","author":"GGJM Kuiper","year":"1997","unstructured":"Kuiper GGJM, Carlsson B, Grandien K, Enmark E, H\u00e4ggblad J, Nilsson S, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors \u03b1 and \u03b2. Endocrinology. 1997;138(3):863\u201370.","journal-title":"Endocrinology"},{"issue":"6","key":"2223_CR30","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1161\/CIRCRESAHA.110.236687","volume":"109","author":"E Murphy","year":"2011","unstructured":"Murphy E. Estrogen signaling and cardiovascular disease. Circ Res. 2011;109(6):687\u201396.","journal-title":"Circ Res"},{"issue":"9","key":"2223_CR31","doi-asserted-by":"publisher","first-page":"488","DOI":"10.5483\/BMBRep.2016.49.9.141","volume":"49","author":"R Barakat","year":"2016","unstructured":"Barakat R, Oakley O, Kim H, Jin J, Ko CJ. Extra-gonadal sites of estrogen biosynthesis and function. BMB Rep. 2016;49(9):488\u201396.","journal-title":"BMB Rep."},{"issue":"2","key":"2223_CR32","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1080\/tam.5.2.98.102","volume":"5","author":"A Vermeulen","year":"2002","unstructured":"Vermeulen A, Kaufman JM, Goemaere S, Van Pottelberg I. Estradiol in elderly men. Aging Male. 2002;5(2):98\u2013102.","journal-title":"Aging Male."},{"issue":"5","key":"2223_CR33","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1177\/1073858413519865","volume":"20","author":"LA Bean","year":"2014","unstructured":"Bean LA, Ianov L, Foster TC. Estrogen receptors, the hippocampus, and memory. Neurosci. 2014;20(5):534\u201345. https:\/\/doi.org\/10.1177\/1073858413519865.","journal-title":"Neurosci"},{"key":"2223_CR34","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3389\/fnagi.2017.00406","volume":"9","author":"P Gaignard","year":"2017","unstructured":"Gaignard P, Liere P, Th\u00e9rond P, Schumacher M, Slama A, Guennoun R. Role of sex hormones on brain mitochondrial function, with special reference to aging and neurodegenerative diseases. Front Aging Neurosci. 2017;9:406.","journal-title":"Front Aging Neurosci."},{"issue":"3","key":"2223_CR35","first-page":"320","volume":"27","author":"T Mcmahon","year":"2015","unstructured":"Mcmahon T, Van Zijl PCM, Gilad AA. NIH Public Access. 2015;27(3):320\u201331.","journal-title":"NIH Public Access."},{"issue":"1","key":"2223_CR36","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2174\/187152608784139659","volume":"8","author":"C Gonz\u00e1lez","year":"2008","unstructured":"Gonz\u00e1lez C, D\u00edaz F, Alonso A. Neuroprotective effects of estrogens: cross-talk between estrogen and intracellular insulin signalling. Infect Disord Drug Targets. 2008;8(1):65\u20137.","journal-title":"Infect Disord Drug Targets"},{"issue":"1","key":"2223_CR37","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/jnr.10833","volume":"75","author":"A Quesada","year":"2004","unstructured":"Quesada A, Micevych PE. Estrogen interacts with the IGF-1 system to protect nigrostriatal dopamine and maintain motoric behavior after 6-hydroxdopamine lesions. J Neurosci Res. 2004;75(1):107\u201316. https:\/\/doi.org\/10.1002\/jnr.10833.","journal-title":"J Neurosci Res"},{"issue":"43","key":"2223_CR38","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.yfrne.2016.09.003","volume":"2016","author":"JL Labandeira-Garcia","year":"2016","unstructured":"Labandeira-Garcia JL, Rodriguez-Perez AI, Valenzuela R, Costa-Besada MA, Guerra MJ. Menopause and Parkinson\u2019s disease. Interaction between estrogens and brain renin\u2013angiotensin system in dopaminergic degeneration. Front Neuroendocrinol. 2016;2016(43):44\u201359.","journal-title":"Front Neuroendocrinol."},{"issue":"8","key":"2223_CR39","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1136\/jnnp.2006.103788","volume":"78","author":"CA Haaxma","year":"2007","unstructured":"Haaxma CA, Bloem BR, Borm GF, Oyen WJG, Leenders KL, Eshuis S, et al. Gender differences in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 2007;78(8):819\u201324.","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"2","key":"2223_CR40","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.expneurol.2009.03.003","volume":"217","author":"M Hirohata","year":"2009","unstructured":"Hirohata M, Ono K, Morinaga A, Ikeda T, Yamada M. Anti-aggregation and fibril-destabilizing effects of sex hormones on \u03b1-synuclein fibrils in vitro. Exp Neurol. 2009;217(2):434\u20139.","journal-title":"Exp Neurol"},{"key":"2223_CR41","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fnagi.2018.00370\/full","volume":"22","author":"G Zhang","year":"2018","unstructured":"Zhang G, Xia Y, Wan F, Ma K, Guo X, Kou L, et al. New perspectives on roles of alpha-synuclein in Parkinson\u2019s disease. Front Aging Neurosci. 2018;22:10. https:\/\/doi.org\/10.3389\/fnagi.2018.00370\/full.","journal-title":"Front Aging Neurosci"},{"issue":"10","key":"2223_CR42","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.4155\/fmc-2017-0016","volume":"9","author":"SK Singh","year":"2017","unstructured":"Singh SK, Dutta A, Modi G. \u03b1-Synuclein aggregation modulation: an emerging approach for the treatment of Parkinson\u2019s disease. Future Med Chem. 2017;9(10):1039\u201353. https:\/\/doi.org\/10.4155\/fmc-2017-0016.","journal-title":"Future Med Chem"},{"key":"2223_CR43","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1056\/NEJM2003ra020003","volume":"348","author":"RL Nussbaum","year":"2003","unstructured":"Nussbaum RL, Ellis CE. Alzheimer\u2019s disease and Parkinson\u2019s Disease. N Engl J Med. 2003;348:1356\u201364.","journal-title":"N Engl J Med"},{"issue":"2","key":"2223_CR44","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0733-8619(05)70259-0","volume":"14","author":"CM Tanner","year":"1996","unstructured":"Tanner CM, Goldman SM. Epidemiology of Parkinson\u2019s disease. Neurol Clin. 1996;14(2):317\u201335.","journal-title":"Neurol Clin"},{"issue":"2","key":"2223_CR45","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0733-8619(18)30212-3","volume":"10","author":"CM Tanner","year":"1992","unstructured":"Tanner CM. Epidemiology of Parkinson\u2019s disease. Neurol Clin. 1992;10(2):317\u201329.","journal-title":"Neurol Clin"},{"issue":"4","key":"2223_CR46","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.euroneuro.2005.04.007","volume":"15","author":"S Von Campenhausen","year":"2005","unstructured":"Von Campenhausen S, Bornschein B, Wick R, B\u00f6tzel K, Sampaio C, Poewe W, et al. Prevalence and incidence of Parkinson\u2019s disease in Europe. Eur Neuropsychopharmacol. 2005;15(4):473\u201390.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"8","key":"2223_CR47","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1007\/s00415-016-8384-9","volume":"264","author":"M Picillo","year":"2017","unstructured":"Picillo M, Nicoletti A, Fetoni V, Garavaglia B, Barone P, Pellecchia MT. The relevance of gender in Parkinson\u2019s disease: a review. J Neurol. 2017;264(8):1583\u2013607.","journal-title":"J Neurol"},{"key":"2223_CR48","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.expneurol.2014.03.010","volume":"259","author":"KM Smith","year":"2014","unstructured":"Smith KM, Dahodwala N. Sex differences in Parkinson\u2019s disease and other movement disorders. Exp Neurol. 2014;259:44\u201356.","journal-title":"Exp Neurol"},{"issue":"9","key":"2223_CR49","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1056\/NEJM199702273360907","volume":"336","author":"D Le Roith","year":"1997","unstructured":"Le Roith D. Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors. N Engl J Med. 1997;336(9):633\u201340.","journal-title":"N Engl J Med."},{"issue":"1","key":"2223_CR50","first-page":"1","volume":"1","author":"I Mart\u00edn-Estal","year":"2015","unstructured":"Mart\u00edn-Estal I, De la Garza R, Castilla-Cortazar I. Intrauterine Growth Retardation (IUGR) as a novel condition deficiency of Insulin-like growth. Retard Intrauter Growth. 2015;1(1):1.","journal-title":"Retard Intrauter Growth."},{"key":"2223_CR51","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0012-1606(80)90166-9","volume":"75","author":"AJ D\u2019Ercole","year":"1980","unstructured":"D\u2019Ercole AJ, Applewhite GT, Underwood LE. Evidence that somatomedin is synthesized by multiple tissues in the fetus. Dev Biol. 1980;75:315\u201328.","journal-title":"Dev Biol."},{"key":"2223_CR52","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/1479-5876-10-224","volume":"10","author":"JE Puche","year":"2012","unstructured":"Puche JE, Castilla-Cort\u00e1zar I. Human conditions of insulin-like growth factor-I (IGF-I) deficiency. J Transl Med. 2012;10:224.","journal-title":"J Transl Med"},{"issue":"170","key":"2223_CR53","first-page":"1","volume":"4","author":"I Mart\u00edn-Estal","year":"2016","unstructured":"Mart\u00edn-Estal I, de la Garza RG, Castilla-Cort\u00e1zar I. Intrauterine growth retardation (IUGR) as a novel condition of insulin-like growth factor-1 (IGF-1) deficiency. Rev Physiol Biochem Pharmacol. 2016;4(170):1\u201335.","journal-title":"Rev Physiol Biochem Pharmacol"},{"issue":"1","key":"2223_CR54","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12967-015-0762-z","volume":"14","author":"GA Aguirre","year":"2016","unstructured":"Aguirre GA, De Ita JR, de la Garza RG, Castilla-Cortazar I. Insulin-like growth factor-1 deficiency and metabolic syndrome. J Transl Med. 2016;14(1):3.","journal-title":"J Transl Med"},{"key":"2223_CR55","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1749-6632.1993.tb26203.x","volume":"692","author":"CA Bondy","year":"1993","unstructured":"Bondy CA, Lee WH. Patterns of insulin-like growth factor and IGF receptor gene expression in the brain. Functional implications. Ann N Y Acad Sci. 1993;692:33\u201343.","journal-title":"Ann N Y Acad Sci."},{"issue":"1","key":"2223_CR56","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0169-328X(91)90054-2","volume":"10","author":"MA Bach","year":"1991","unstructured":"Bach MA, Shen-Orr Z, Lowe WL, Roberts CT, LeRoith D. Insulin-like growth factor I mRNA levels are developmentally regulated in specific regions of the rat brain. Brain Res Mol Brain Res. 1991;10(1):43\u20138.","journal-title":"Brain Res Mol Brain Res"},{"key":"2223_CR57","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/0-387-26274-1_8","volume":"567","author":"GJ Popken","year":"2005","unstructured":"Popken GJ, Dechert-Zeger M, Ye P, D\u2019Ercole AJ. Brain development. Adv Exp Med Biol. 2005;567:187\u2013220.","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"2223_CR58","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/jnr.490280212","volume":"28","author":"A Baron-Van Evercooren","year":"1991","unstructured":"Baron-Van Evercooren A, Olichon-Berthe C, Kowalski A, Visciano G, Van Obberghen E. Expression of IGF-I and insulin receptor genes in the rat central nervous system: a developmental, regional, and cellular analysis. J Neurosci Res. 1991;28(2):244\u201353.","journal-title":"J Neurosci Res"},{"issue":"5","key":"2223_CR59","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1210\/endo.135.5.7525251","volume":"135","author":"RR Reinhardt","year":"1994","unstructured":"Reinhardt RR, Bondy CA. Insulin-like growth factors cross the blood-brain barrier. Endocrinology. 1994;135(5):1753\u201361.","journal-title":"Endocrinology"},{"issue":"1","key":"2223_CR60","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.neulet.2012.01.077","volume":"513","author":"X Gong","year":"2012","unstructured":"Gong X, Ma M, Fan X, Li M, Liu Q, Liu X, et al. Down-regulation of IGF-1\/IGF-1R in hippocampus of rats with vascular dementia. Neurosci Lett. 2012;513(1):20\u20134.","journal-title":"Neurosci Lett"},{"issue":"2","key":"2223_CR61","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.arr.2005.02.001","volume":"4","author":"WE Sonntag","year":"2005","unstructured":"Sonntag WE, Ramsey M, Carter CS. Growth hormone and insulin-like growth factor-1 (IGF-1) and their influence on cognitive aging. Ageing Res Rev. 2005;4(2):195\u2013212.","journal-title":"Ageing Res Rev."},{"issue":"2","key":"2223_CR62","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/0006-8993(89)91678-8","volume":"503","author":"A Adem","year":"1989","unstructured":"Adem A, Jossan SS, D\u2019Argy R, Gillberg PG, Nordberg A, Winblad B, et al. Insulin-like growth factor 1 (IGF-1) receptors in the human brain: quantitative autoradiographic localization. Brain Res. 1989;503(2):299\u2013303.","journal-title":"Brain Res"},{"issue":"12","key":"2223_CR63","doi-asserted-by":"publisher","first-page":"117862641984217","DOI":"10.1177\/1178626419842176","volume":"17","author":"MS Lewitt","year":"2019","unstructured":"Lewitt MS, Boyd GW. The role of insulin-like growth factors and insulin-like growth factor-binding proteins in the nervous system. Biochem Insights. 2019;17(12):117862641984217. https:\/\/doi.org\/10.1177\/1178626419842176.","journal-title":"Biochem Insights"},{"issue":"3","key":"2223_CR64","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3233\/JAD-2009-0995","volume":"16","author":"M Tong","year":"2009","unstructured":"Tong M, Dong M, de la Monte SM. Brain insulin-like growth factor and neurotrophin resistance in Parkinson\u2019s disease and dementia with Lewy bodies: potential role of manganese neurotoxicity. J Alzheimers Dis. 2009;16(3):585\u201399.","journal-title":"J Alzheimers Dis"},{"key":"2223_CR65","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fnins.2018.00073\/full","volume":"20","author":"L Yang","year":"2018","unstructured":"Yang L, Wang H, Liu L, Xie A. The role of insulin\/IGF-1\/PI3K\/Akt\/GSK3\u03b2 signaling in Parkinson\u2019s disease dementia. Front Neurosci. 2018;20:12. https:\/\/doi.org\/10.3389\/fnins.2018.00073\/full.","journal-title":"Front Neurosci"},{"key":"2223_CR66","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.brainres.2008.08.089","volume":"1240","author":"JK Morris","year":"2008","unstructured":"Morris JK, Zhang H, Gupte AA, Bomhoff GL, Stanford JA, Geiger PC. Measures of striatal insulin resistance in a 6-hydroxydopamine model of Parkinson\u2019s disease. Brain Res. 2008;1240:185\u201395.","journal-title":"Brain Res"},{"issue":"4","key":"2223_CR67","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1172\/JCI59903","volume":"122","author":"K Talbot","year":"2012","unstructured":"Talbot K, Wang H-Y, Kazi H, Han L-Y, Bakshi KP, Stucky A, et al. Demonstrated brain insulin resistance in Alzheimer\u2019s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Investig. 2012;122(4):1316\u201338.","journal-title":"J Clin Investig"},{"issue":"4","key":"2223_CR68","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nrn3209","volume":"13","author":"AM Fernandez","year":"2012","unstructured":"Fernandez AM, Torres-Alem\u00e1n I. The many faces of insulin-like peptide signalling in the brain. Nat Rev Neurosci. 2012;13(4):225\u201339.","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"2223_CR69","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1530\/acta.0.1070171","volume":"107","author":"M B\u00e4ckstr\u00f6m","year":"1984","unstructured":"B\u00e4ckstr\u00f6m M, Hall K, Sara V. Somatomedin levels in cerebrospinal fluid from adults with pituitary disorders. Acta Endocrinol. 1984;107(2):171\u20138.","journal-title":"Acta Endocrinol"},{"key":"2223_CR70","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/nm1202-793","volume":"8","author":"E Carro","year":"2002","unstructured":"Carro E, Trejo JL, Gomez-Isla T, LeRoith D, Torres-Aleman I. Serum insulin-like growth factor I regulates brain amyloid-beta levels. Nat Med. 2002;8:1390\u20137.","journal-title":"Nat Med"},{"issue":"4","key":"2223_CR71","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.addr.2009.02.003","volume":"61","author":"B Kalmar","year":"2009","unstructured":"Kalmar B, Greensmith L. Induction of heat shock proteins for protection against oxidative stress. Adv Drug Deliv Rev. 2009;61(4):310\u20138.","journal-title":"Adv Drug Deliv Rev"},{"key":"2223_CR72","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/1479-5876-9-123","volume":"9","author":"M Garcia-Fernandez","year":"2011","unstructured":"Garcia-Fernandez M, Sierra I, Puche JE, Guerra L, Castilla-Cortazar I. Liver mitochondrial dysfunction is reverted by insulin-like growth factor II (IGF-II) in aging rats. J Transl Med. 2011;9:123.","journal-title":"J Transl Med."},{"key":"2223_CR73","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1479-5876-9-103","volume":"9","author":"I Castilla-Cort\u00e1zar","year":"2011","unstructured":"Castilla-Cort\u00e1zar I, Garc\u00eda-Fern\u00e1ndez M, Delgado G, Puche JE, Sierra I, Barhoum R, et al. Hepatoprotection and neuroprotection induced by low doses of IGF-II in aging rats. J Transl Med. 2011;9:103.","journal-title":"J Transl Med."},{"issue":"2","key":"2223_CR74","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S0026-0495(98)90007-5","volume":"37","author":"KR Duffy","year":"1988","unstructured":"Duffy KR, Pardridge WM, Rosenfeld RG. Human blood-brain barrier insulin-like growth factor receptor. Metabolism. 1988;37(2):136\u201340.","journal-title":"Metabolism."},{"key":"2223_CR75","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.neuroscience.2016.03.056","volume":"325","author":"AH Dyer","year":"2016","unstructured":"Dyer AH, Vahdatpour C, Sanfeliu A, Tropea D. The role of Insulin-Like Growth Factor 1 (IGF-1) in brain development, maturation and neuroplasticity. Neuroscience. 2016;325:89\u201399.","journal-title":"Neuroscience"},{"issue":"12","key":"2223_CR76","doi-asserted-by":"publisher","first-page":"5958","DOI":"10.1210\/en.2008-0920","volume":"149","author":"A Joseph D\u2019Ercole","year":"2008","unstructured":"Joseph D\u2019Ercole A, Ye P. Minireview: expanding the mind: insulin-like growth factor I and brain development. Endocrinology. 2008;149(12):5958\u201362.","journal-title":"Endocrinology."},{"issue":"14","key":"2223_CR77","doi-asserted-by":"publisher","first-page":"6041","DOI":"10.1523\/JNEUROSCI.22-14-06041.2002","volume":"22","author":"P Ye","year":"2002","unstructured":"Ye P, Li L, Richards RG, DiAugustine RP, D\u2019Ercole AJ. Myelination is altered in insulin-like growth factor-I null mutant mice. J Neurosci. 2002;22(14):6041\u201351.","journal-title":"J Neurosci"},{"issue":"8","key":"2223_CR78","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1111\/j.0953-816X.2004.03320.x","volume":"19","author":"GJ Popken","year":"2004","unstructured":"Popken GJ, Hodge RD, Ye P, Zhang J, Ng W, O\u2019Kusky JR, et al. In vivo effects of insulin-like growth factor-I (IGF-I) on prenatal and early postnatal development of the central nervous system. Eur J Neurosci. 2004;19(8):2056\u201368.","journal-title":"Eur J Neurosci"},{"issue":"1","key":"2223_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jnr.20688","volume":"83","author":"P Ye","year":"2006","unstructured":"Ye P, D\u2019Ercole AJ. Insulin-like growth factor actions during development of neural stem cells and progenitors in the central nervous system. J Neurosci Res. 2006;83(1):1\u20136.","journal-title":"J Neurosci Res"},{"issue":"3","key":"2223_CR80","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.yfrne.2012.06.002","volume":"33","author":"J O\u2019Kusky","year":"2012","unstructured":"O\u2019Kusky J, Ye P. Neurodevelopmental effects of insulin-like growth factor signaling. Front Neuroendocrinol. 2012;33(3):230\u201351.","journal-title":"Front Neuroendocrinol"},{"key":"2223_CR81","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1471-2202-15-91","volume":"15","author":"TJ Huat","year":"2014","unstructured":"Huat TJ, Khan AA, Pati S, Mustafa Z, Abdullah JM, Jaafar H. IGF-1 enhances cell proliferation and survival during early differentiation of mesenchymal stem cells to neural progenitor-like cells. BMC Neurosci. 2014;15:91.","journal-title":"BMC Neurosci."},{"key":"2223_CR82","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1100\/tsw.2006.22","volume":"6","author":"ND Aberg","year":"2006","unstructured":"Aberg ND, Brywe KG, Isgaard J. Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain. Sci World J. 2006;6:53\u201380.","journal-title":"Sci World J"},{"issue":"22","key":"2223_CR83","doi-asserted-by":"publisher","first-page":"8435","DOI":"10.1523\/JNEUROSCI.20-22-08435.2000","volume":"20","author":"JR O\u2019Kusky","year":"2000","unstructured":"O\u2019Kusky JR, Ye P, D\u2019Ercole AJ. Insulin-like growth factor-I promotes neurogenesis and synaptogenesis in the hippocampal dentate gyrus during postnatal development. J Neurosci. 2000;20(22):8435\u201342.","journal-title":"J Neurosci"},{"issue":"5","key":"2223_CR84","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/j.1460-9568.2009.06870.x","volume":"30","author":"A Hurtado-Chong","year":"2009","unstructured":"Hurtado-Chong A, Yusta-Boyo MJ, Verga\u00f1o-Vera E, Bulfone A, de Pablo F, Vicario-Abej\u00f3n C. IGF-I promotes neuronal migration and positioning in the olfactory bulb and the exit of neuroblasts from the subventricular zone. Eur J Neurosci. 2009;30(5):742\u201355.","journal-title":"Eur J Neurosci"},{"issue":"31","key":"2223_CR85","doi-asserted-by":"publisher","first-page":"13064","DOI":"10.1073\/pnas.0808400106","volume":"106","author":"K Oishi","year":"2009","unstructured":"Oishi K, Watatani K, Itoh Y, Okano H, Guillemot F, Nakajima K, et al. Selective induction of neocortical GABAergic neurons by the PDK1-Akt pathway through activation of Mash1. Proc Natl Acad Sci USA. 2009;106(31):13064\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2223_CR86","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.mcn.2007.10.016","volume":"37","author":"JL Trejo","year":"2008","unstructured":"Trejo JL, Llorens-Mart\u00edn MV, Torres-Alem\u00e1n I. The effects of exercise on spatial learning and anxiety-like behavior are mediated by an IGF-I-dependent mechanism related to hippocampal neurogenesis. Mol Cell Neurosci. 2008;37(2):402\u201311.","journal-title":"Mol Cell Neurosci"},{"issue":"1","key":"2223_CR87","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1089\/neu.2009.1002","volume":"27","author":"SK Madathil","year":"2010","unstructured":"Madathil SK, Evans HN, Saatman KE. Temporal and regional changes in IGF-1\/IGF-1R signaling in the mouse brain after traumatic brain injury. J Neurotrauma. 2010;27(1):95\u2013107.","journal-title":"J Neurotrauma"},{"issue":"2","key":"2223_CR88","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/0169-328X(95)00346-T","volume":"38","author":"AC Sandberg Nordqvist","year":"1996","unstructured":"Sandberg Nordqvist AC, von Holst H, Holmin S, Sara VR, Bellander BM, Schalling M. Increase of insulin-like growth factor (IGF)-1, IGF binding protein-2 and -4 mRNAs following cerebral contusion. Brain Res Mol Brain Res. 1996;38(2):285\u201393.","journal-title":"Brain Res Mol Brain Res"},{"issue":"2","key":"2223_CR89","doi-asserted-by":"publisher","first-page":"433","DOI":"10.5114\/aoms.2015.50976","volume":"11","author":"W Wang","year":"2015","unstructured":"Wang W, Li D, Li Q, Wang L, Bai G, Yang T, et al. Erythropoietin promotes peripheral nerve regeneration in rats by upregulating expression of insulin-like growth factor-1. Arch Med Sci. 2015;11(2):433\u20137.","journal-title":"Arch Med Sci."},{"issue":"2","key":"2223_CR90","first-page":"103","volume":"32","author":"J Isgaard","year":"2007","unstructured":"Isgaard J, Aberg D, Nilsson M. Protective and regenerative effects of the GH\/IGF-I axis on the brain. Minerva Endocrinol. 2007;32(2):103\u201313.","journal-title":"Minerva Endocrinol"},{"issue":"1","key":"2223_CR91","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.neulet.2012.05.029","volume":"520","author":"AP Corvin","year":"2012","unstructured":"Corvin AP, Molinos I, Little G, Donohoe G, Gill M, Morris DW, et al. Insulin-like growth factor 1 (IGF1) and its active peptide (1-3)IGF1 enhance the expression of synaptic markers in neuronal circuits through different cellular mechanisms. Neurosci Lett. 2012;520(1):51\u20136.","journal-title":"Neurosci Lett"},{"issue":"2","key":"2223_CR92","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1177\/1073858408331371","volume":"15","author":"M Llorens-Mart\u00edn","year":"2009","unstructured":"Llorens-Mart\u00edn M, Torres-Alem\u00e1n I, Trejo JL. Mechanisms mediating brain plasticity: IGF1 and adult hippocampal neurogenesis. Neuroscientist. 2009;15(2):134\u201348.","journal-title":"Neuroscientist"},{"issue":"5","key":"2223_CR93","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nn1689","volume":"9","author":"D Tropea","year":"2006","unstructured":"Tropea D, Kreiman G, Lyckman A, Mukherjee S, Yu H, Horng S, et al. Gene expression changes and molecular pathways mediating activity-dependent plasticity in visual cortex. Nat Neurosci. 2006;9(5):660\u20138.","journal-title":"Nat Neurosci"},{"issue":"2\u20133","key":"2223_CR94","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1055\/s-2007-978707","volume":"31","author":"I Torres-Aleman","year":"1999","unstructured":"Torres-Aleman I. Insulin-like growth factors as mediators of functional plasticity in the adult brain. Horm Metab Res. 1999;31(2\u20133):114\u20139.","journal-title":"Horm Metab Res."},{"issue":"10","key":"2223_CR95","doi-asserted-by":"publisher","first-page":"6349","DOI":"10.1074\/jbc.M114.634154","volume":"290","author":"SMP Jacobo","year":"2015","unstructured":"Jacobo SMP, Kazlauskas A. Insulin-like growth factor 1 (IGF-1) stabilizes nascent blood vessels. J Biol Chem. 2015;290(10):6349\u201360.","journal-title":"J Biol Chem"},{"issue":"3","key":"2223_CR96","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.pneurobio.2006.08.003","volume":"80","author":"L Bonfanti","year":"2006","unstructured":"Bonfanti L. PSA-NCAM in mammalian structural plasticity and neurogenesis. Prog Neurobiol. 2006;80(3):129\u201364.","journal-title":"Prog Neurobiol"},{"issue":"6","key":"2223_CR97","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/jnc.12363","volume":"126","author":"HJ Monzo","year":"2013","unstructured":"Monzo HJ, Park TIH, Dieriks BV, Jansson D, Faull RLM, Dragunow M, et al. Insulin and IGF1 modulate turnover of polysialylated neural cell adhesion molecule (PSA-NCAM) in a process involving specific extracellular matrix components. J Neurochem. 2013;126(6):758\u201370.","journal-title":"J Neurochem"},{"issue":"1\u20132","key":"2223_CR98","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jneuroim.2006.06.014","volume":"179","author":"RH McCusker","year":"2006","unstructured":"McCusker RH, McCrea K, Zunich S, Dantzer R, Broussard SR, Johnson RW, et al. Insulin-like growth factor-I enhances the biological activity of brain-derived neurotrophic factor on cerebrocortical neurons. J Neuroimmunol. 2006;179(1\u20132):186\u201390.","journal-title":"J Neuroimmunol"},{"issue":"1","key":"2223_CR99","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1677\/joe.1.06058","volume":"185","author":"P Mendez","year":"2005","unstructured":"Mendez P, Azcoitia I, Garcia-Segura LM. Interdependence of oestrogen and insulin-like growth factor-I in the brain: potential for analysing neuroprotective mechanisms. J Endocrinol. 2005;185(1):11\u20137.","journal-title":"J Endocrinol"},{"issue":"8","key":"2223_CR100","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1097\/00001756-200006050-00027","volume":"11","author":"GP Cardona-G\u00f3mez","year":"2000","unstructured":"Cardona-G\u00f3mez GP, Trejo JL, Fernandez AM, Garcia-Segura LM. Estrogen receptors and insulin-like growth factor-I receptors mediate estrogen-dependent synaptic plasticity. NeuroReport. 2000;11(8):1735\u20138.","journal-title":"NeuroReport"},{"issue":"Suppl A","key":"2223_CR101","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1016\/j.ghir.2004.03.010","volume":"14","author":"JL Trejo","year":"2004","unstructured":"Trejo JL, Carro E, Lopez-Lopez C, Torres-Aleman I. Role of serum insulin-like growth factor I in mammalian brain aging. Growth Horm IGF Res. 2004;14(Suppl A):S39\u201343.","journal-title":"Growth Horm IGF Res."},{"issue":"3","key":"2223_CR102","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1677\/joe.1.06631","volume":"189","author":"J Svensson","year":"2006","unstructured":"Svensson J, Diez M, Engel J, Wass C, Tivesten A, Jansson J-O, et al. Endocrine, liver-derived IGF-I is of importance for spatial learning and memory in old mice. J Endocrinol. 2006;189(3):617\u201327.","journal-title":"J Endocrinol"},{"issue":"4","key":"2223_CR103","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/jnr.10791","volume":"74","author":"SB Lupien","year":"2003","unstructured":"Lupien SB, Bluhm EJ, Ishii DN. Systemic insulin-like growth factor-I administration prevents cognitive impairment in diabetic rats, and brain IGF regulates learning\/memory in normal adult rats. J Neurosci Res. 2003;74(4):512\u201323.","journal-title":"J Neurosci Res"},{"issue":"1\u20132","key":"2223_CR104","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.brainres.2005.01.007","volume":"1037","author":"BA Hoshaw","year":"2005","unstructured":"Hoshaw BA, Malberg JE, Lucki I. Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects. Brain Res. 2005;1037(1\u20132):204\u20138.","journal-title":"Brain Res"},{"issue":"21","key":"2223_CR105","doi-asserted-by":"publisher","first-page":"10203","DOI":"10.1073\/pnas.91.21.10203","volume":"91","author":"MA Castro-Alamancos","year":"1994","unstructured":"Castro-Alamancos MA, Torres-Aleman I. Learning of the conditioned eye-blink response is impaired by an antisense insulin-like growth factor I oligonucleotide. Proc Natl Acad Sci USA. 1994;91(21):10203\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2223_CR106","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bbi.2005.02.003","volume":"20","author":"R-M Bluth\u00e9","year":"2006","unstructured":"Bluth\u00e9 R-M, Kelley KW, Dantzer R. Effects of insulin-like growth factor-I on cytokine-induced sickness behavior in mice. Brain Behav Immun. 2006;20(1):57\u201363.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"2223_CR107","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0165-3806(93)90086-P","volume":"74","author":"LC Ang","year":"1993","unstructured":"Ang LC, Bhaumick B, Juurlink BH. Neurite promoting activity of insulin, insulin-like growth factor I and nerve growth factor on spinal motoneurons is astrocyte dependent. Brain Res Dev Brain Res. 1993;74(1):83\u20138.","journal-title":"Brain Res Dev Brain Res"},{"issue":"6","key":"2223_CR108","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1002\/jnr.490400605","volume":"40","author":"M Pomerance","year":"1995","unstructured":"Pomerance M, Gavaret JM, Breton M, Pierre M. Effects of growth factors on phosphatidylinositol-3 kinase in astroglial cells. J Neurosci Res. 1995;40(6):737\u201346.","journal-title":"J Neurosci Res"},{"issue":"1","key":"2223_CR109","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1006\/exnr.1996.0115","volume":"140","author":"WM Zawada","year":"1996","unstructured":"Zawada WM, Kirschman DL, Cohen JJ, Heidenreich KA, Freed CR. Growth factors rescue embryonic dopamine neurons from programmed cell death. Exp Neurol. 1996;140(1):60\u20137.","journal-title":"Exp Neurol"},{"issue":"1\u20132","key":"2223_CR110","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0006-8993(96)01186-9","volume":"746","author":"S Masuda","year":"1997","unstructured":"Masuda S, Chikuma M, Sasaki R. Insulin-like growth factors and insulin stimulate erythropoietin production in primary cultured astrocytes. Brain Res. 1997;746(1\u20132):63\u201370.","journal-title":"Brain Res"},{"issue":"6","key":"2223_CR111","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1210\/endo.134.6.8194486","volume":"134","author":"P Tranque","year":"1994","unstructured":"Tranque P, Naftolin F, Robbins R. Differential regulation of astrocyte plasminogen activators by insulin-like growth factor-I and epidermal growth factor. Endocrinology. 1994;134(6):2606\u201313.","journal-title":"Endocrinology"},{"issue":"4","key":"2223_CR112","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1210\/endo.133.4.7691580","volume":"133","author":"SL Bradshaw","year":"1993","unstructured":"Bradshaw SL, Han VK. Hormonal regulation of astroglial insulin-like growth factor (IGF)-binding protein gene expression by IGFs and insulin. Endocrinology. 1993;133(4):1767\u201377.","journal-title":"Endocrinology"},{"issue":"1","key":"2223_CR113","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/jnr.10734","volume":"74","author":"ND Aberg","year":"2003","unstructured":"Aberg ND, Blomstrand F, Aberg MAI, Bj\u00f6rklund U, Carlsson B, Carlsson-Skwirut C, et al. Insulin-like growth factor-I increases astrocyte intercellular gap junctional communication and connexin43 expression in vitro. J Neurosci Res. 2003;74(1):12\u201322.","journal-title":"J Neurosci Res"},{"issue":"Pt 20","key":"2223_CR114","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1242\/jcs.114.20.3717","volume":"114","author":"K Suzuki","year":"2001","unstructured":"Suzuki K, Ikegaya Y, Matsuura S, Kanai Y, Endou H, Matsuki N. Transient upregulation of the glial glutamate transporter GLAST in response to fibroblast growth factor, insulin-like growth factor and epidermal growth factor in cultured astrocytes. J Cell Sci. 2001;114(Pt 20):3717\u201325.","journal-title":"J Cell Sci"},{"issue":"6","key":"2223_CR115","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1097\/00001756-199504190-00013","volume":"6","author":"U Sonnewald","year":"1995","unstructured":"Sonnewald U, Wang AY, Petersen SB, Westergaard N, Schousboe A, Erikson R, et al. 13C NMR study of IGF-I- and insulin-effects on mitochondrial function in cultured brain cells. NeuroReport. 1995;6(6):878\u201380.","journal-title":"NeuroReport"},{"issue":"2","key":"2223_CR116","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/j.1471-4159.1992.tb09750.x","volume":"58","author":"R Dringen","year":"1992","unstructured":"Dringen R, Hamprecht B. Glucose, insulin, and insulin-like growth factor I regulate the glycogen content of astroglia-rich primary cultures. J Neurochem. 1992;58(2):511\u20137.","journal-title":"J Neurochem"},{"issue":"5","key":"2223_CR117","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1210\/endo-128-5-2548","volume":"128","author":"BA Masters","year":"1991","unstructured":"Masters BA, Werner H, Roberts CT, LeRoith D, Raizada MK. Developmental regulation of insulin-like growth factor-I-stimulated glucose transporter in rat brain astrocytes. Endocrinology. 1991;128(5):2548\u201357.","journal-title":"Endocrinology"},{"issue":"5","key":"2223_CR118","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/S0047-6374(01)00354-2","volume":"123","author":"V Spina Purrello","year":"2002","unstructured":"Spina Purrello V, Cormaci G, Denaro L, Reale S, Costa A, Lalicata C, et al. Effect of growth factors on nuclear and mitochondrial ADP-ribosylation processes during astroglial cell development and aging in culture. Mech Ageing Dev. 2002;123(5):511\u201320.","journal-title":"Mech Ageing Dev"},{"issue":"1","key":"2223_CR119","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1006\/abbi.1993.1576","volume":"307","author":"T Matsuda","year":"1993","unstructured":"Matsuda T, Murata Y, Kawamura N, Hayashi M, Tamada K, Takuma K, et al. Selective induction of alpha 1 isoform of (Na++K\u2009+)-ATPase by insulin\/insulin-like growth factor-I in cultured rat astrocytes. Arch Biochem Biophys. 1993;307(1):175\u201382.","journal-title":"Arch Biochem Biophys"},{"issue":"12","key":"2223_CR120","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/S0166-2236(97)01139-9","volume":"20","author":"JL Ridet","year":"1997","unstructured":"Ridet JL, Malhotra SK, Privat A, Gage FH. Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci. 1997;20(12):570\u20137.","journal-title":"Trends Neurosci"},{"issue":"7","key":"2223_CR121","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1210\/endo.138.7.5284","volume":"138","author":"HJ Walter","year":"1997","unstructured":"Walter HJ, Berry M, Hill DJ, Logan A. Spatial and temporal changes in the insulin-like growth factor (IGF) axis indicate autocrine\/paracrine actions of IGF-I within wounds of the rat brain. Endocrinology. 1997;138(7):3024\u201334.","journal-title":"Endocrinology"},{"issue":"2","key":"2223_CR122","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/ijc.2910500210","volume":"50","author":"HN Antoniades","year":"1992","unstructured":"Antoniades HN, Galanopoulos T, Neville-Golden J, Maxwell M. Expression of insulin-like growth factors I and II and their receptor mRNAs in primary human astrocytomas and meningiomas; in vivo studies using in situ hybridization and immunocytochemistry. Int J Cancer. 1992;50(2):215\u201322.","journal-title":"Int J Cancer"},{"key":"2223_CR123","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s13105-016-0545-x","volume":"73","author":"VJ Lara-Diaz","year":"2017","unstructured":"Lara-Diaz VJ, Castilla-Cortazar I, Mart\u00edn-Estal I, Garc\u00eda-Magari\u00f1o M, Aguirre GA, Puche JE, et al. IGF-1 modulates gene expression of proteins involved in inflammation, cytoskeleton, and liver architecture. J Physiol Biochem. 2017;73:245\u201358.","journal-title":"J Physiol Biochem."},{"issue":"1","key":"2223_CR124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0168-8278(17)31017-6","volume":"66","author":"LA Morales-Garza","year":"2017","unstructured":"Morales-Garza LA, Puche JE, de la Garza RG, Mu\u00f1oz-Mor\u00f3n \u00da, Castilla-Cort\u00e1zar I. Experimental approach to IGF-1 therapy in acute liver damage: acute injury by carbon tetrachloride in controls and mice with partial IGF-1 deficiency. J Hepatol. 2017;66(1):1\u201314.","journal-title":"J Hepatol"},{"issue":"2","key":"2223_CR125","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1210\/edrv-16-2-143","volume":"16","author":"DEREK LEROITH","year":"1995","unstructured":"LeRoith D, Werner H, Beitner-Johnson D, Roberts CT. Molecular and cellular aspects of the insulin-like growth factor I receptor. In: Endocrine reviews, vol. 16. 1995. p. 143\u201363.","journal-title":"Endocrine Reviews"},{"issue":"2","key":"2223_CR126","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ghir.2007.01.006","volume":"17","author":"S Fernandez","year":"2007","unstructured":"Fernandez S, Fernandez AM, Lopez-Lopez C, Torres-Aleman I. Emerging roles of insulin-like growth factor-I in the adult brain. Growth Horm IGF Res. 2007;17(2):89\u201395.","journal-title":"Growth Horm IGF Res."},{"issue":"5","key":"2223_CR127","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1210\/en.2007-1190","volume":"149","author":"M Garc\u00eda-Fern\u00e1ndez","year":"2008","unstructured":"Garc\u00eda-Fern\u00e1ndez M, Delgado G, Puche JE, Gonz\u00e1lez-Bar\u00f3n S, Castilla Cort\u00e1zar I. Low doses of insulin-like growth factor I improve insulin resistance, lipid metabolism, and oxidative damage in aging rats. Endocrinology. 2008;149(5):2433\u201342.","journal-title":"Endocrinology"},{"key":"2223_CR128","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s13105-013-0287-y","volume":"70","author":"I Castilla-Cortazar","year":"2013","unstructured":"Castilla-Cortazar I, Guerra L, Puche JE, Munoz U, Barhoum R, Escudero E, et al. An experimental model of partial insulin-like growth factor-1 deficiency in mice. J Physiol Biochem. 2013;70:129\u201339.","journal-title":"J Physiol Biochem"},{"issue":"1","key":"2223_CR129","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/biof.1255","volume":"42","author":"JE Puche","year":"2016","unstructured":"Puche JE, Mu\u00f1oz \u00da, Garc\u00eda-Magari\u00f1o M, S\u00e1daba MC, Castilla-Cort\u00e1zar I. Partial IGF-1 deficiency induces brain oxidative damage and edema, which are ameliorated by replacement therapy. Biofactors. 2016;42(1):60\u201379.","journal-title":"Biofactors"},{"key":"2223_CR130","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.neuroscience.2019.01.041","volume":"404","author":"I Castilla-Cort\u00e1zar","year":"2019","unstructured":"Castilla-Cort\u00e1zar I, Iturrieta I, Garc\u00eda-Magari\u00f1o M, Puche JE, Mart\u00edn-Estal I, Aguirre GA, et al. Neurotrophic factors and their receptors are altered by the mere partial IGF-1 deficiency. Neuroscience. 2019;404:445\u201358.","journal-title":"Neuroscience"},{"issue":"8","key":"2223_CR131","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/BF03346653","volume":"33","author":"M Gasperi","year":"2010","unstructured":"Gasperi M, Castellano AE. Growth hormone\/insulin-like growth factor I axis in neurodegenerative diseases. J Endocrinol Investig. 2010;33(8):587\u201391.","journal-title":"J Endocrinol Investig"},{"issue":"1","key":"2223_CR132","doi-asserted-by":"publisher","first-page":"T171","DOI":"10.1530\/JME-18-0093","volume":"61","author":"S Gubbi","year":"2018","unstructured":"Gubbi S, Quipildor GF, Barzilai N, Huffman DM, Milman S. 40 years of IGF1: IGF1: the Jekyll and Hyde of the aging brain. J Mol Endocrinol. 2018;61(1):T171\u201385.","journal-title":"J Mol Endocrinol"},{"key":"2223_CR133","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00608\/full","author":"F Ghazi Sherbaf","year":"2018","unstructured":"Ghazi Sherbaf F, Mohajer B, Ashraf-Ganjouei A, Mojtahed Zadeh M, Javinani A, Sanjari Moghaddam H, et al. Serum insulin-like growth factor-1 in parkinson\u2019s disease; study of cerebrospinal fluid biomarkers and white matter microstructure. Front Endocrinol. 2018. https:\/\/doi.org\/10.3389\/fendo.2018.00608\/full.","journal-title":"Front Endocrinol"},{"issue":"10","key":"2223_CR134","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1111\/j.1532-5415.2005.53524.x","volume":"53","author":"T Watanabe","year":"2005","unstructured":"Watanabe T, Miyazaki A, Katagiri T, Yamamoto H, Idei T, Iguchi T. Relationship between serum insulin-like growth factor-1 levels and Alzheimer\u2019s disease and vascular dementia. J Am Geriatr Soc. 2005;53(10):1748\u201353.","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"2223_CR135","first-page":"152","volume":"2","author":"Z Laron","year":"1966","unstructured":"Laron Z, Pertzelan A, Mannheimer S. Genetic pituitary dwarfism with high serum concentation of growth hormone\u2014a new inborn error of metabolism? Isr J Med Sci. 1966;2(2):152\u20135.","journal-title":"Isr J Med Sci."},{"issue":"7","key":"2223_CR136","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1056\/NEJM199602153340711","volume":"334","author":"Z Laron","year":"1996","unstructured":"Laron Z. Short stature due to genetic defects affecting growth hormone activity. N Engl J Med. 1996;334(7):463\u20135.","journal-title":"N Engl J Med"},{"issue":"3","key":"2223_CR137","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1515\/JPEM.1995.8.3.149","volume":"8","author":"B Klinger","year":"1995","unstructured":"Klinger B, Laron Z. Three year IGF-I treatment of children with Laron syndrome. J Pediatr Endocrinol Metab. 1995;8(3):149\u201358.","journal-title":"J Pediatr Endocrinol Metab."},{"key":"2223_CR138","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-17-0126","author":"I Castilla-Cortazar","year":"2017","unstructured":"Castilla-Cortazar I, De Ita JR, Aguirre GA, Garc\u00eda-Magari\u00f1o M, Mart\u00edn-Estal I, Lara-Diaz VJ, et al. Growth hormone insensitivity: Mexican case report. Endocrinol Diabetes Metab Case Rep. 2017. https:\/\/doi.org\/10.1530\/EDM-17-0126.","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"4","key":"2223_CR139","first-page":"359","volume":"47","author":"A Wu","year":"1974","unstructured":"Wu A, Grant DB, Hambley J, Levi AJ. Reduced serum somatomedin activity in patients with chronic liver disease. Clin Sci Mol Med. 1974;47(4):359\u201366.","journal-title":"Clin Sci Mol Med"},{"issue":"1","key":"2223_CR140","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0168-8278(97)80026-8","volume":"26","author":"A Picardi","year":"1997","unstructured":"Picardi A, de Oliveira AC, Muguerza B, Tosar A, Quiroga J, Castilla-Cort\u00e1zar I, et al. Low doses of insulin-like growth factor-I improve nitrogen retention and food efficiency in rats with early cirrhosis. J Hepatol. 1997;26(1):191\u2013202.","journal-title":"J Hepatol"},{"issue":"2","key":"2223_CR141","doi-asserted-by":"publisher","first-page":"G319","DOI":"10.1152\/ajpgi.2000.279.2.G319","volume":"279","author":"M Pascual","year":"2000","unstructured":"Pascual M, Castilla-Cortazar I, Urdaneta E, Quiroga J, Garcia M, Picardi A, et al. Altered intestinal transport of amino acids in cirrhotic rats: the effect of insulin-like growth factor-I. Am J Physiol Gastrointest Liver Physiol. 2000;279(2):G319\u201324.","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"2223_CR142","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1471-230X-4-12","volume":"4","author":"I Castilla-Cort\u00e1zar","year":"2004","unstructured":"Castilla-Cort\u00e1zar I, Pascual M, Urdaneta E, Pardo J, Puche JE, Vivas B, et al. Jejunal microvilli atrophy and reduced nutrient transport in rats with advanced liver cirrhosis: improvement by Insulin-like Growth Factor I. BMC Gastroenterol. 2004;4:12.","journal-title":"BMC Gastroenterol."},{"issue":"1 Pt 1","key":"2223_CR143","first-page":"G37","volume":"276","author":"I Castilla-Cort\u00e1zar","year":"1999","unstructured":"Castilla-Cort\u00e1zar I, Picardi A, Tosar A, Ainz\u00faa J, Urdaneta E, Garc\u00eda M, et al. Effect of insulin-like growth factor I on in vivo intestinal absorption of d-galactose in cirrhotic rats. Am J Physiol. 1999;276(1 Pt 1):G37\u201342.","journal-title":"Am J Physiol."},{"issue":"4","key":"2223_CR144","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1053\/gast.1997.v113.pm9322513","volume":"113","author":"I Castilla-Cortazar","year":"1997","unstructured":"Castilla-Cortazar I, Prieto J, Urdaneta E, Pascual M, Nu\u00f1ez M, Zudaire E, et al. Impaired intestinal sugar transport in cirrhotic rats: correction by low doses of insulin-like growth factor I. Gastroenterology. 1997;113(4):1180\u20137.","journal-title":"Gastroenterology"},{"issue":"1","key":"2223_CR145","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S0168-8278(98)80211-0","volume":"28","author":"A Cemborain","year":"1998","unstructured":"Cemborain A, Castilla-Cort\u00e1zar I, Garc\u00eda M, Quiroga J, Muguerza B, Picardi A, et al. Osteopenia in rats with liver cirrhosis: beneficial effects of IGF-I treatment. J Hepatol. 1998;28(1):122\u201331.","journal-title":"J Hepatol"},{"issue":"2","key":"2223_CR146","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/BF03179904","volume":"56","author":"A Cemborain","year":"2000","unstructured":"Cemborain A, Castilla-Cort\u00e1zar I, Garc\u00eda M, Muguerza B, Delgado G, D\u00edaz-S\u00e1nchez M, et al. Effects of IGF-I treatment on osteopenia in rats with advanced liver cirrhosis. J Physiol Biochem. 2000;56(2):91\u20139.","journal-title":"J Physiol Biochem."},{"issue":"6","key":"2223_CR147","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1053\/jhep.2000.7886","volume":"31","author":"I Castilla-Cortazar","year":"2000","unstructured":"Castilla-Cortazar I, Quiroga J, Prieto J. Insulin-like growth factor-I, liver function, and hypogonadism in rats with experimentally induced cirrhosis. Hepatology. 2000;31(6):1379.","journal-title":"Hepatology"},{"issue":"3","key":"2223_CR148","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/hep.510310308","volume":"31","author":"I Castilla-Cortazar","year":"2000","unstructured":"Castilla-Cortazar I, Garcia M, Quiroga J, Diez N, Diez-Caballero F, Calvo A, et al. Insulin-like growth factor-I reverts testicular atrophy in rats with advanced cirrhosis. Hepatology. 2000;31(3):592\u2013600.","journal-title":"Hepatology"},{"key":"2223_CR149","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1034\/j.1600-0676.2001.210607.x","volume":"21","author":"I Castilla-Cort\u00e1zar","year":"2001","unstructured":"Castilla-Cort\u00e1zar I, Aliaga-Montilla MA, Salvador J, Garc\u00eda M, Delgado G, Gonz\u00e1lez-Bar\u00f3n S, Quiroga J, Prieto J. Insulin-like growth factor-I restores the reduced somatostatinergic tone controlling growth hormone secretion in cirrhotic rats. Liver. 2001;21:405\u20139.","journal-title":"Liver"},{"key":"2223_CR150","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.3748\/wjg.14.2731","volume":"14","author":"R P\u00e9rez","year":"2008","unstructured":"P\u00e9rez R, Garc\u00eda-Fern\u00e1ndez M, D\u00edaz-S\u00e1nchez M, Puche JE, Delgado G, Conchillo M, et al. Mitochondrial protection by low doses of insulin-like growth factor-I in experimental cirrhosis. World J Gastroenterol. 2008;14:2731\u20139.","journal-title":"World J Gastroenterol"},{"key":"2223_CR151","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-230X-5-7","volume":"5","author":"M Garc\u00eda-Fern\u00e1ndez","year":"2005","unstructured":"Garc\u00eda-Fern\u00e1ndez M, Castilla-Cort\u00e1zar I, D\u00edaz-Sanchez M, Navarro I, Puche JE, Castilla A, et al. Antioxidant effects of insulin-like growth factor-I (IGF-I) in rats with advanced liver cirrhosis. BMC Gastroenterol. 2005;5:7.","journal-title":"BMC Gastroenterol."},{"issue":"2\u20133","key":"2223_CR152","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0925-4439(01)00045-X","volume":"1536","author":"B Muguerza","year":"2001","unstructured":"Muguerza B, Castilla-Cort\u00e1zar I, Garc\u00eda M, Quiroga J, Santidri\u00e1n S, Prieto J. Antifibrogenic effect in vivo of low doses of insulin-like growth factor-I in cirrhotic rats. Biochim Biophys Acta. 2001;1536(2\u20133):185\u201395.","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"2223_CR153","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1053\/gast.1997.v113.pm9352873","volume":"113","author":"I Castilla-Cortazar","year":"1997","unstructured":"Castilla-Cortazar I, Garcia M, Muguerza B, Quiroga J, Perez R, Santidrian S, et al. Hepatoprotective effects of insulin-like growth factor I in rats with carbon tetrachloride-induced cirrhosis. Gastroenterology. 1997;113(5):1682\u201391.","journal-title":"Gastroenterology"},{"issue":"4","key":"2223_CR154","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.jhep.2005.03.025","volume":"43","author":"M Conchillo","year":"2005","unstructured":"Conchillo M, de Knegt RJ, Payeras M, Quiroga J, Sangro B, Herrero J-I, et al. Insulin-like growth factor I (IGF-I) replacement therapy increases albumin concentration in liver cirrhosis: results of a pilot randomized controlled clinical trial. J Hepatol. 2005;43(4):630\u20136.","journal-title":"J Hepatol"},{"issue":"11 Suppl Procee","key":"2223_CR155","first-page":"96","volume":"28","author":"GP Ceda","year":"2005","unstructured":"Ceda GP, Dall\u2019Aglio E E, Maggio M, Lauretani F, Bandinelli S, Falzoi C, et al. Clinical implications of the reduced activity of the GH-IGF-I axis in older men. J Endocrinol Investig. 2005;28(11 Suppl Proceedings):96\u2013100.","journal-title":"J Endocrinol Investig."},{"issue":"6","key":"2223_CR156","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.neurobiolaging.2004.07.010","volume":"26","author":"LY Sun","year":"2005","unstructured":"Sun LY, Al-Regaiey K, Masternak MM, Wang J, Bartke A. Local expression of GH and IGF-1 in the hippocampus of GH-deficient long-lived mice. Neurobiol Aging. 2005;26(6):929\u201337.","journal-title":"Neurobiol Aging"},{"issue":"8","key":"2223_CR157","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1210\/endo.138.8.5330","volume":"138","author":"WE Sonntag","year":"1997","unstructured":"Sonntag WE, Lynch CD, Cooney PT, Hutchins PM. Decreases in cerebral microvasculature with age are associated with the decline in growth hormone and insulin-like growth factor 1. Endocrinology. 1997;138(8):3515\u201320.","journal-title":"Endocrinology"},{"issue":"7","key":"2223_CR158","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1210\/en.2005-0058","volume":"146","author":"WE Sonntag","year":"2005","unstructured":"Sonntag WE, Carter CS, Ikeno Y, Ekenstedt K, Carlson CS, Loeser RF, et al. Adult-onset growth hormone and insulin-like growth factor I deficiency reduces neoplastic disease, modifies age-related pathology, and increases life span. Endocrinology. 2005;146(7):2920\u201332.","journal-title":"Endocrinology"},{"issue":"9","key":"2223_CR159","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1096\/fj.02-0819fje","volume":"17","author":"I Shimokawa","year":"2003","unstructured":"Shimokawa I, Higami Y, Tsuchiya T, Otani H, Komatsu T, Chiba T, et al. Life span extension by reduction of the growth hormone-insulin-like growth factor-1 axis: relation to caloric restriction. FASEB J. 2003;17(9):1108\u20139.","journal-title":"FASEB J."},{"issue":"Suppl","key":"2223_CR160","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1530\/eje.0.151s023","volume":"151","author":"M Holzenberger","year":"2004","unstructured":"Holzenberger M. The GH\/IGF-I axis and longevity. Eur J Endocrinol. 2004;151(Suppl):S23\u20137.","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2223_CR161","doi-asserted-by":"publisher","first-page":"E604","DOI":"10.1152\/ajpendo.00012.2006","volume":"291","author":"WE Sonntag","year":"2006","unstructured":"Sonntag WE, Bennett C, Ingram R, Donahue A, Ingraham J, Chen H, et al. Growth hormone and IGF-I modulate local cerebral glucose utilization and ATP levels in a model of adult-onset growth hormone deficiency. Am J Physiol Endocrinol Metab. 2006;291(3):E604\u201310.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"2223_CR162","doi-asserted-by":"publisher","first-page":"E353","DOI":"10.1152\/ajpendo.00339.2006","volume":"292","author":"M Maggio","year":"2007","unstructured":"Maggio M, Lauretani F, Ceda GP, Bandinelli S, Basaria S, Paolisso G, et al. Association of hormonal dysregulation with metabolic syndrome in older women: data from the InCHIANTI study. Am J Physiol Endocrinol Metab. 2007;292(1):E353\u20138.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"2223_CR163","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/gerona\/61.1.28","volume":"61","author":"L Groban","year":"2006","unstructured":"Groban L, Pailes NA, Bennett CDL, Carter CS, Chappell MC, Kitzman DW, et al. Growth hormone replacement attenuates diastolic dysfunction and cardiac angiotensin II expression in senescent rats. J Gerontol A Biol Sci Med Sci. 2006;61(1):28\u201335.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"3","key":"2223_CR164","doi-asserted-by":"publisher","first-page":"H1398","DOI":"10.1152\/ajpheart.01036.2006","volume":"292","author":"Q Li","year":"2007","unstructured":"Li Q, Wu S, Li S-Y, Lopez FL, Du M, Kajstura J, et al. Cardiac-specific overexpression of insulin-like growth factor 1 attenuates aging-associated cardiac diastolic contractile dysfunction and protein damage. Am J Physiol Heart Circ Physiol. 2007;292(3):H1398\u2013403.","journal-title":"Am J Physiol Heart Circ Physiol."},{"issue":"1","key":"2223_CR165","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/1479-5876-10-224","volume":"10","author":"JE Puche","year":"2012","unstructured":"Puche JE, Castilla-Cort\u00e1zar I. Human conditions of insulin-like growth factor-I (IGF-I) deficiency. J Transl Med. 2012;10(1):224.","journal-title":"J Transl Med"},{"issue":"3","key":"2223_CR166","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1210\/endo.141.3.7385","volume":"141","author":"P Tollet-Egnell","year":"2000","unstructured":"Tollet-Egnell P, Flores-Morales A, Odeberg J, Lundeberg J, Norstedt G. Differential cloning of growth hormone-regulated hepatic transcripts in the aged rat. Endocrinology. 2000;141(3):910\u201321.","journal-title":"Endocrinology"},{"key":"2223_CR167","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1210\/en.2007-1563","volume":"149","author":"JE Puche","year":"2008","unstructured":"Puche JE, Garc\u00eda-Fern\u00e1ndez M, Muntan\u00e9 J, Rioja J, Gonz\u00e1lez-Bar\u00f3n S, Cortazar IC. Low doses of insulin-like growth factor-I induce mitochondrial protection in aging rats. Endocrinology. 2008;149:2620\u20137.","journal-title":"Endocrinology"},{"key":"2223_CR168","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1210\/en.2007-1190","volume":"149","author":"M Garc\u00eda-Fern\u00e1ndez","year":"2008","unstructured":"Garc\u00eda-Fern\u00e1ndez M, Delgado G, Puche JE, Gonz\u00e1lez-Bar\u00f3n S, Cort\u00e1zar IC. Low doses of insulin-like growth factor I improve insulin resistance, lipid metabolism, and oxidative damage in aging rats. Endocrinology. 2008;149:2433\u201342.","journal-title":"Endocrinology"},{"issue":"4","key":"2223_CR169","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1365-2265.2005.02237.x","volume":"62","author":"MT Pellecchia","year":"2005","unstructured":"Pellecchia MT, Pivonello R, Salvatore E, Faggiano A, Barone P, De Michele G, et al. Growth hormone response to arginine test distinguishes multiple system atrophy from Parkinson\u2019s disease and idiopathic late-onset cerebellar ataxia. Clin Endocrinol. 2005;62(4):428\u201333.","journal-title":"Clin Endocrinol"},{"issue":"2","key":"2223_CR170","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000119395","volume":"35","author":"R Volpi","year":"1997","unstructured":"Volpi R, Caffarra P, Scaglioni A, Boni S, Saginario A, Chiodera P, et al. Defective 5-HT 1-receptor-mediated neurotransmission in the control of growth hormone secretion in Parkinson\u2019s disease. Neuropsychobiology. 1997;35(2):79\u201383.","journal-title":"Neuropsychobiology."},{"issue":"3","key":"2223_CR171","doi-asserted-by":"publisher","first-page":"e0150552","DOI":"10.1371\/journal.pone.0150552","volume":"11","author":"FP Bernhard","year":"2016","unstructured":"Bernhard FP, Heinzel S, Binder G, Weber K, Apel A, Roeben B, et al. Insulin-like growth factor 1 (IGF-1) in Parkinson\u2019s disease: potential as trait-, progression- and prediction marker and confounding factors. PLoS ONE. 2016;11(3):e0150552.","journal-title":"PLoS ONE"},{"issue":"7","key":"2223_CR172","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1001\/archneurol.2011.129","volume":"68","author":"J Godau","year":"2011","unstructured":"Godau J, Knauel K, Weber K, Brockmann K, Maetzler W, Binder G, et al. Serum insulinlike growth factor 1 as possible marker for risk and early diagnosis of Parkinson disease. Arch Neurol. 2011;68(7):925\u201331.","journal-title":"Arch Neurol"},{"issue":"5","key":"2223_CR173","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1136\/jnnp.2009.175752","volume":"81","author":"J Godau","year":"2010","unstructured":"Godau J, Herfurth M, Kattner B, Gasser T, Berg D. Increased serum insulin-like growth factor 1 in early idiopathic Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 2010;81(5):536\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"2223_CR174","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.jocn.2009.08.013","volume":"17","author":"F Mashayekhi","year":"2010","unstructured":"Mashayekhi F, Mirzajani E, Naji M, Azari M. Expression of insulin-like growth factor-1 and insulin-like growth factor binding proteins in the serum and cerebrospinal fluid of patients with Parkinson\u2019s disease. J Clin Neurosci. 2010;17(5):623\u20137.","journal-title":"J Clin Neurosci."},{"issue":"2","key":"2223_CR175","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.parkreldis.2013.11.005","volume":"20","author":"A Numao","year":"2014","unstructured":"Numao A, Suzuki K, Miyamoto M, Miyamoto T, Hirata K. Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson\u2019s disease, multiple system atrophy and progressive supranuclear palsy. Park Relat Disord. 2014;20(2):212\u20136.","journal-title":"Park Relat Disord."},{"issue":"4","key":"2223_CR176","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/j.1600-0404.2009.01185.x","volume":"121","author":"U Fiszer","year":"2010","unstructured":"Fiszer U, Micha\u0142owska M, Baranowska B, Woli\u0144ska-Witort E, Jeske W, Jethon M, et al. Leptin and ghrelin concentrations and weight loss in Parkinson\u2019s disease. Acta Neurol Scand. 2010;121(4):230\u20136.","journal-title":"Acta Neurol Scand"},{"key":"2223_CR177","doi-asserted-by":"publisher","first-page":"132464","DOI":"10.1155\/2009\/132464","volume":"2009","author":"D Tuncel","year":"2009","unstructured":"Tuncel D, Inanc Tolun F, Toru I. Serum insulin-like growth factor-1 and nitric oxide levels in Parkinson\u2019s disease. Mediators Inflamm. 2009;2009:132464.","journal-title":"Mediators Inflamm"},{"issue":"5","key":"2223_CR178","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1111\/ene.12137","volume":"21","author":"MT Pellecchia","year":"2014","unstructured":"Pellecchia MT, Santangelo G, Picillo M, Pivonello R, Longo K, Pivonello C, et al. Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-na\u00efve Parkinson\u2019s disease. Eur J Neurol. 2014;21(5):802\u20137.","journal-title":"Eur J Neurol"},{"issue":"7","key":"2223_CR179","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1007\/s00415-013-6851-0","volume":"260","author":"M Picillo","year":"2013","unstructured":"Picillo M, Erro R, Santangelo G, Pivonello R, Longo K, Pivonello C, et al. Insulin-like growth factor-1 and progression of motor symptoms in early, drug-na\u00efve Parkinson\u2019s disease. J Neurol. 2013;260(7):1724\u201330.","journal-title":"J Neurol"},{"issue":"10","key":"2223_CR180","doi-asserted-by":"publisher","first-page":"e0186508","DOI":"10.1371\/journal.pone.0186508","volume":"12","author":"M Picillo","year":"2017","unstructured":"Picillo M, Pivonello R, Santangelo G, Pivonello C, Savastano R, Auriemma R, et al. Serum IGF-1 is associated with cognitive functions in early, drug-naive Parkinson\u2019s disease. PLoS ONE. 2017;12(10):e0186508.","journal-title":"PLoS ONE"},{"issue":"12","key":"2223_CR181","doi-asserted-by":"publisher","first-page":"e0144755","DOI":"10.1371\/journal.pone.0144755","volume":"10","author":"D-H Li","year":"2015","unstructured":"Li D-H, He Y-C, Quinn TJ, Liu J. Serum insulin-like growth factor-1 in patients with de novo, drug na\u00efve Parkinson\u2019s disease: a meta-analysis. PLoS ONE. 2015;10(12):e0144755.","journal-title":"PLoS ONE"},{"issue":"5646","key":"2223_CR182","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, et al. alpha-Synuclein locus triplication causes Parkinson\u2019s disease. Science. 2003;302(5646):841.","journal-title":"Science"},{"issue":"22","key":"2223_CR183","doi-asserted-by":"publisher","first-page":"6455","DOI":"10.1111\/j.1742-4658.2009.07344.x","volume":"276","author":"U Kumari","year":"2009","unstructured":"Kumari U, Tan EK. LRRK2 in Parkinson\u2019s disease: genetic and clinical studies from patients. FEBS J. 2009;276(22):6455\u201363.","journal-title":"FEBS J"},{"issue":"1","key":"2223_CR184","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jprot.2009.07.007","volume":"73","author":"V Licker","year":"2009","unstructured":"Licker V, K\u00f6vari E, Hochstrasser DF, Burkhard PR. Proteomics in human Parkinson\u2019s disease research. J Proteomics. 2009;73(1):10\u201329.","journal-title":"J Proteomics."},{"issue":"6645","key":"2223_CR185","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature. 1997;388(6645):839\u201340.","journal-title":"Nature"},{"issue":"2","key":"2223_CR186","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1159\/000325028","volume":"19","author":"J-Y Chung","year":"2011","unstructured":"Chung J-Y, Lee S-J, Lee S-H, Jung YS, Ha N-C, Seol W, et al. Direct interaction of \u03b1-synuclein and AKT regulates IGF-1 signaling: implication of Parkinson disease. Neurosignals. 2011;19(2):86\u201396.","journal-title":"Neurosignals"},{"issue":"3","key":"2223_CR187","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.bbrc.2009.05.089","volume":"385","author":"S-Y Kao","year":"2009","unstructured":"Kao S-Y. Rescue of \u03b1-synuclein cytotoxicity by insulin-like growth factors. Biochem Biophys Res Commun. 2009;385(3):434\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"2223_CR188","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1016\/j.neurobiolaging.2014.01.021","volume":"35","author":"W Kim","year":"2014","unstructured":"Kim W, Lee Y, McKenna ND, Yi M, Simunovic F, Wang Y, et al. miR-126 contributes to Parkinson\u2019s disease by dysregulating the insulin-like growth factor\/phosphoinositide 3-kinase signaling. Neurobiol Aging. 2014;35(7):1712\u201321.","journal-title":"Neurobiol Aging"},{"issue":"4","key":"2223_CR189","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1079\/BJN20041337","volume":"93","author":"AG Dulloo","year":"2005","unstructured":"Dulloo AG, Montani J-P. Obesity in Parkinson\u2019s disease patients on electrotherapy: collateral damage, adiposity rebound or secular trends? Br J Nutr. 2005;93(4):417\u20139.","journal-title":"Br J Nutr"},{"issue":"6","key":"2223_CR190","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/aje\/kwh059","volume":"159","author":"H Chen","year":"2004","unstructured":"Chen H, Zhang SM, Schwarzschild MA, Hern\u00e1n MA, Willett WC, Ascherio A. Obesity and the risk of Parkinson\u2019s disease. Am J Epidemiol. 2004;159(6):547\u201355.","journal-title":"Am J Epidemiol"},{"issue":"3","key":"2223_CR191","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.molmed.2013.01.002","volume":"19","author":"JA Santiago","year":"2013","unstructured":"Santiago JA, Potashkin JA. Shared dysregulated pathways lead to Parkinson\u2019s disease and diabetes. Trends Mol Med. 2013;19(3):176\u201386.","journal-title":"Trends Mol Med."},{"key":"2223_CR192","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.tox.2013.02.002","volume":"307","author":"I Zaganas","year":"2013","unstructured":"Zaganas I, Kapetanaki S, Mastorodemos V, Kanavouras K, Colosio C, Wilks MF, et al. Linking pesticide exposure and dementia: what is the evidence? Toxicology. 2013;307:3\u201311.","journal-title":"Toxicology"},{"issue":"5","key":"2223_CR193","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.neuro.2012.05.011","volume":"33","author":"C Freire","year":"2012","unstructured":"Freire C, Koifman S. Pesticide exposure and Parkinson\u2019s disease: epidemiological evidence of association. Neurotoxicology. 2012;33(5):947\u201371.","journal-title":"Neurotoxicology."},{"issue":"9","key":"2223_CR194","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S1474-4422(03)00501-5","volume":"2","author":"DA Di Monte","year":"2003","unstructured":"Di Monte DA. The environment and Parkinson\u2019s disease: is the nigrostriatal system preferentially targeted by neurotoxins? Lancet Neurol. 2003;2(9):531\u20138.","journal-title":"Lancet Neurol."},{"key":"2223_CR195","doi-asserted-by":"crossref","unstructured":"Aguirre GA, Gonz\u00e1lez-Guerra JL, Espinosa L, Castilla-Cortazar I. Insulin-like growth factor 1 in the cardiovascular system. In: Rev Physiol Biochem Pharmacol. 2018.","DOI":"10.1007\/112_2017_8"},{"issue":"1","key":"2223_CR196","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.gene.2013.07.085","volume":"532","author":"L Zuo","year":"2013","unstructured":"Zuo L, Motherwell MS. The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson\u2019s disease. Gene. 2013;532(1):18\u201323.","journal-title":"Gene"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-020-02223-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-020-02223-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-020-02223-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T12:55:09Z","timestamp":1722430509000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-020-02223-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,11]]},"references-count":196,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2223"],"URL":"https:\/\/doi.org\/10.1186\/s12967-020-02223-0","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,11]]},"assertion":[{"value":"23 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"70"}}